*Corresponding Author


  • Wang F*, Wu R, Kumar S, Noyes A, Fortunato G, Vergara CM, Grady J. Guideline adherence of pharmacotherapy for chronic heart failure with reduced ejection fraction: a cross sectional study of a Medicaid and Medicare population within a safety-net health-care system. Corresponding author. In progress
  • Wang F, Wang T, Zhou J, Tang H, Giovenale S, Ma X. Cardiovascular effects among-incretin-based therapies in type 2 diabetes – a network meta-analysis. In progress
  • Tang H, Wang, F, Wang T. Incretin-Based Therapies and Risk of Retinopathy in Patients with Type 2 Diabetes: A Meta-Analysis of Three Large Randomized Trials.


  • Wang F*, Zassman S, Goldberg PA. rDNA insulin glargine U300-a critical appraisal. Diabetes Metab Syndr Obes. 2016; 9:425-441. Published online December 2, 2016.
  • Sundeep Bath and Fei Wang. Drug Information Update: Hartford Hospital. Health Literacy and Implications for Patient Care. Conn Med. 2016 Aug 2016;80 (7):427-432
  • Wang T, Wang F*, Zhou J, Tang H, Giovenale S. Adverse Effects of Incretin–based Therapies on Major Cardiovascular and Arrhythmia Events: Meta-analysis of Randomized Trials. Diabetes Metab Res Rev. 2016 Apr 2; PubMed PMID: 27037787. DOI: 10.1002/dmrr.2804.
  • Wang T, Wang F, Xin X, Pleasants RA, Shi L. Methods for using microblogs for health communication with a pharmacist-based account. Patient Educ Couns. Published online: March 7 2016. DOI: 10.1016/j.pec.2016.03.003
  • Glasser I, Wang F, Reardon J, Vergara C.D., Salvietti R, Acevedo M, Santana B, Fortunato G. Improving COPD Care in a Medically Underserved Primary Care Clinic: A Qualitative Study of Patient Perspectives. COPD. 2016 Jan 25:1-6. PMID: 26807853


  • Xiaohui Xie, Fei Wang*, Jiayu Cui. The impact of obesity in managing diabetes. Journal of Chinese Pharmaceutical Sciences. 2015; 24(6):412-418. DOI: 10.5246/jcps.2015.06.053.
  • Wang, T., Wang, F., Gou, Z., Tang, H., Li, C., Shi, L. and Zhai, S. Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies. Diabetes Obes Metab. 2015; 17(1): 32-41; DOI: 10.1111/dom.12386. (IF=6.36)


  • Wang T, Gou Z, Wang F, Ma M, Zhai S. Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies. PLoS One. 4;9(8):e103798. DOI: 10.1371/journal.pone.0103798. PMID: 25089625


  • Wang F*, Corman A, Sounthonevat C, Baldino J. MTM considerations in osteoporosis care. Current issues for prevention and treatment. Drug Topics 2013; 157(10):36-48 
  • Wang T, Wang F, Shi L. The use of microblog-based case studies in a pharmacotherapy introduction class in China. BMC Medical Education 2013, 13:120. DOI: 10 1186/1472-6920-13-120. (IF=1.41)


  • Wang F*., Surh J., Kaur M. Insulin degludec as an ultra-long-acting basal insulin once a day: A systematic review. Diabetes Metab Syndr Obes. 2012; 5:191-204
  • Colby JA, Wang F, Chhabra J, Pérez-Escamilla R. Predictors of medication adherence in an urban Latino community with healthcare disparities. J Immigr Minor Health. 2012; 14(4):589-595 DOI: 10.1007/s10903-011-9545-7


  • Kim A, Chiu A, Barone M, Avino D, Wang F, Coleman CI, Phung OJ. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 2011;111:1720-1729 DOI:10.1016/j.jada.2011.08.009


  • Dang D.K., Wang F., Calis K.A. Dysmenorrhea. In: Borgelt LM, O’Connell MB, Smith JA, Calis KA, eds. Women’s Health Across the Lifespan. A Pharmacotherapeutic Approach. 1st ed. American Society of Health-System Pharmacists, Inc. 2010: 181-193. 


  • Sobieraj DM, Wang F*, Kirton OC. Warfarin Resistance after Total Gastrectomy and Roux-en-Y Esophagojejunostomy. 2008; 28(12):1537-41 (PMID: 19025435) DOI:10.1592/phco.28.12.1537
  • Vergara, C, Wang F, Banfi V. Hypertension in Puerto Ricans in the Continental United States. P R Health Sci J. 2008; 27(3):247-55 (PMID: 18782971)
  • Kopecky R, Wang F*, Reagan L, Czarnecki GR. An Update on Recent Advances in Asthma Management. Conn Med. 2008; 72(6):335-339 (PMID: 18610706)


  • Wang F*, Troutman WG, Seo T, Peak A, Rosenberg JM. Drug Information Education in Doctor of Pharmacy Programs. Am J Pharm Educ. 2006; 70(3); 51( PMID: 17136172)
  • Vergara C, Venkatachalam V, Sundararahan Wang F, Banfi V. “Perioperative Assessment of Patients with Renal Insufficiency.” The Physicians Information and Education Resource (PIER). American College of Physicians-American Society of Internal Medicine (ACP-ASIM). Online Clinical Guidance published March 2006.


  • Vergara C, Martin AM, Wang F, Horowitz S. Awareness about Factors that Affect the Management of Hypertension in Puerto Rican Patients. Conn Med. 2004; 68(5):269-76. (PMID: 15171262)
  • Wang F*, Vergara CM, Carabino JM, Desilets A, Vasquez R. Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms. Am J Health Syst Pharm. 2004;61(15):1604-8. (PMID: 15372837)


  • Wang F*, Carabino JM, Vergara CM: Insulin glargine: a systematic review of a long-acting insulin analogue. Clin Ther; 2003; 25(6):1541-77, discussion 1539-40. PMID: 12860485. (IF=2.23)
  • Wang F*, Ross J. Atazanavir: A Novel Azapeptide Inhibitor of HIV-1 Protease. 2003; 38:677-696
  • Vergara CM, Wang F. A Step-by-Step Approach to the Critical Appraisal of Studies with Therapeutic or Preventive Objectives. Conn Med. 2003; 67:195-203. (PMID: 12760079)
  • Coleman CI, Carabino JM, Vergara CM, Wang F. Focus on Vardenafil. An Oral Selective Phosphodiesterase 5 Inhibitor for the Treatment of Erectile Dysfunction. Formulary. 2003; 38:131-48.


  • Wang F*, Alexsunes LM, Reagan LA, Vergara CM. Management of Rosiglitazone Induced Edema: 2 Case Reports and a Review of the Literature. Diabetes Technol Ther. 2002;4(4):505-514 (10.1089/152091502760306599)
  • Carabino J, Wang F. International normalized ratio fluctuation with warfarin and fluorouracil therapy. American Journal of Health-System Pharmacy (Letter). 2002;59(9):875